Research progress on active components from natural medicines inhibiting tumor via epigenetic regulation
Xiao Han1,2, Zhongtian Yang1,3, Xiaoman Chen1
1State Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Abstract:
Tumor is a major disease that seriously threatens human health, and its occurrence and progression involve complex interactions between the genome, epigenome, and environmental factors. Epigenetic modifications-such as DNA methylation, histone modifications, non-coding RNA regulation, and mRNA modifications-play key roles in tumor progression, metastasis, and drug resistance. Natural medicines offer multi-target and holistic regulatory effects, showing unique advantages in cancer therapy. Emerging evidence suggests that natural medicines and its active components can exert anti-tumor activities by modulating epigenetic mechanisms. This review summarizes natural medicines-mediated epigenetic regulation against tumors. It details how natural medicines influences DNA methylation by suppressing DNA methyltransferases (DNMTs) and altering tumor suppressor gene promoter methylation. The modulation of histone modifications through targeting histone deacetylases (HDACs), histone lysine methyltransferases (HKMTs), and histone lysine demethylases (HKDMs) is also discussed. Furthermore, the review covers natural medicines's regulation of non-coding RNAs (e.g., lncRNAs, miRNAs, circRNAs) and their downstream pathways, as well as its role in mRNA modifications, notably N6-methyladenosine (m6A). Overall, this work highlights the epigenetic potential of natural medicines in tumor therapy, enhancing the mechanistic understanding of its anti-tumor effects and supporting natural medicines modernization and precision oncology. However, challenges remain due to natural medicines complexity and tumor epigenetic heterogeneity, calling for deeper investigation and clinical validation.
Insights
Natural medicines can combat tumors by modulating epigenetic mechanisms, including DNA methylation and histone modifications. This review explores how these natural compounds offer a promising avenue for cancer therapy and precision oncology.
Area of Science:
- Oncology
- Epigenetics
- Pharmacology
Background:
- Tumorigenesis involves complex interactions between genome, epigenome, and environment.
- Epigenetic modifications (DNA methylation, histone, non-coding RNA, mRNA) are crucial in tumor progression, metastasis, and drug resistance.
- Natural medicines offer multi-target therapeutic advantages in cancer treatment.
Purpose of the Study:
- To review natural medicines' epigenetic regulation mechanisms against tumors.
- To elucidate how natural compounds modulate DNA methylation, histone modifications, non-coding RNAs, and mRNA modifications in cancer.
- To highlight the potential of natural medicines in modernizing cancer therapy and precision oncology.
Main Methods:
- Literature review summarizing studies on natural medicines and epigenetic regulation in cancer.
- Analysis of mechanisms by which natural medicines influence DNA methylation via DNMTs.
- Examination of natural medicines' effects on histone modifications targeting HDACs, HKMTs, and HKDMs.
- Review of natural medicines' regulation of non-coding RNAs (lncRNAs, miRNAs, circRNAs) and mRNA modifications (m6A).
Main Results:
- Natural medicines suppress DNA methyltransferases (DNMTs) and alter tumor suppressor gene promoter methylation.
- Natural medicines target histone deacetylases (HDACs), histone lysine methyltransferases (HKMTs), and histone lysine demethylases (HKDMs) for anti-tumor effects.
- Natural medicines regulate non-coding RNAs and mRNA modifications like N6-methyladenosine (m6A), impacting downstream cancer pathways.
Conclusions:
- Natural medicines demonstrate significant potential in modulating epigenetic mechanisms for anti-tumor activity.
- Understanding these epigenetic effects enhances mechanistic insights into natural medicines' efficacy in cancer therapy.
- Further investigation and clinical validation are needed to overcome challenges posed by natural medicines' complexity and tumor epigenetic heterogeneity.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Mitogens and the Cell Cycle
Drugs that Stabilize Microtubules
Tumor Immunotherapy


